[Effectiveness of intravenouly administered promazine in acute psychomotor agitation].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002908:Chronic Disease; D004336:Drug Antagonism; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000494:pharmacology; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D011395:Promazine / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D011596:Psychomotor Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy
D007328:Insulin; D011395:Promazine
Skuteczność dozylnego stosowania promazyny w ostrym podnieceniu psychoruchowym.